Paul Rothman, MD

Venture Partner

Paul Rothman is a Venture Partner at Raven. Prior to Raven, Dr. Rothman was the former Dean of the Medical Faculty for the Johns Hopkins University School of Medicine and CEO of Johns Hopkins Medicine from 2012 until 2022. A rheumatologist and molecular immunologist, Dr. Rothman went to Hopkins after serving as Dean of the Carver College of Medicine at the University of Iowa. Prior to that, Paul served as Head of Internal Medicine at the University of Iowa, and Vice Chairman for Research and Founding Director of the Division of Pulmonary, Allergy and Critical Care Medicine at Columbia University College of Physicians and Surgeons. Dr. Rothman trained at Columbia-Presbyterian Medical Center in internal medicine and rheumatology and held a postdoctoral fellowship at Columbia University. Dr Rothman’s research focused on immune system molecules known as cytokines. Specifically, Dr. Rothman investigated the role these molecules play in the normal development of blood cells, as well as the abnormal development of these blood cell that leads to leukemia. Dr. Rothman serves on the boards of Merck, Labcorp as well as the King Faisal Specialty Hospital. Dr. Rothman holds a BS from the Massachusetts Institute of Technology and an MD from Yale University.